Talbot K - Search Results

1

Management of sialorrhoea in motor neuron disease: a survey of current UK practice.

Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, Donaghy C, Ealing J, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Majeed T, Malaspina A, Morrison K, Orrell RW, Pall H, Pinto A, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. Hobson EV, et al. Among authors: talbot k. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):521-7. doi: 10.3109/21678421.2013.790452. Epub 2013 May 7. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23647474

2

Biomarkers in amyotrophic lateral sclerosis.

Turner MR, Kiernan MC, Leigh PN, Talbot K. Turner MR, et al. Among authors: talbot k. Lancet Neurol. 2009 Jan;8(1):94-109. doi: 10.1016/S1474-4422(08)70293-X. Lancet Neurol. 2009. PMID: 19081518 Review.

3

Functional vitamin B12 deficiency.

Turner MR, Talbot K. Turner MR, et al. Among authors: talbot k. Pract Neurol. 2009 Feb;9(1):37-41. doi: 10.1136/jnnp.2008.161968. Pract Neurol. 2009. PMID: 19151237

4

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.

Pereira EA, Turner MR, Wass JA, Talbot K. Pereira EA, et al. Among authors: talbot k. Amyotroph Lateral Scler. 2010;11(1-2):255-7. doi: 10.3109/17482960902870985. Amyotroph Lateral Scler. 2010. PMID: 19634028 Free PMC article.

5

Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS.

Turner MR, Abisgold J, Yeates DG, Talbot K, Goldacre MJ. Turner MR, et al. Among authors: talbot k. J Neurol Sci. 2010 Jan 15;288(1-2):45-8. doi: 10.1016/j.jns.2009.10.010. Epub 2009 Oct 30. J Neurol Sci. 2010. PMID: 19878957

6

Pattern of spread and prognosis in lower limb-onset ALS.

Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ, Talbot K. Turner MR, et al. Among authors: talbot k. Amyotroph Lateral Scler. 2010 Aug;11(4):369-73. doi: 10.3109/17482960903420140. Amyotroph Lateral Scler. 2010. PMID: 20001488 Free PMC article.

7

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.

Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. Turner MR, et al. Among authors: talbot k. J Neurol Sci. 2010 Jul 15;294(1-2):81-5. doi: 10.1016/j.jns.2010.03.028. Epub 2010 May 10. J Neurol Sci. 2010. PMID: 20452624

8

Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review.

Sharma R, Hicks S, Berna CM, Kennard C, Talbot K, Turner MR. Sharma R, et al. Among authors: talbot k. Arch Neurol. 2011 Jul;68(7):857-61. doi: 10.1001/archneurol.2011.130. Arch Neurol. 2011. PMID: 21747027 Review.

9

Catastrophic hyperkalaemia following administration of suxamethonium chloride to a patient with undiagnosed amyotrophic lateral sclerosis.

Turner MR, Lawrence H, Arnold I, Ansorge O, Talbot K. Turner MR, et al. Among authors: talbot k. Clin Med (Lond). 2011 Jun;11(3):292-3. doi: 10.7861/clinmedicine.11-3-292. Clin Med (Lond). 2011. PMID: 21902090 Free PMC article.

10

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS. Al-Chalabi A, et al. BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111. BMC Neurol. 2011. PMID: 21936930 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters